Skip to search formSkip to main contentSkip to account menu

niguldipine

Known as: 3-methyl-5-(3-(4,4-diphenyl-1-piperidinyl)propyl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
  • 2017
  • Corpus ID: 55938813
Novel pharmaceutical compositions containing a combina tion of an angiotensin-II antagonist and a calcium channel blocker such as… 
2010
2010
low affinity state(s) of the DHP receptor, or they can be labelled with DHP-type C a 2 + channel ligands. The aim of this… 
2006
2006
The chemotherapeutic effect of B859-35, the (—)-enantiomerof dihydropyrine 3-methyl-5-3-(4,4-diphenyl-l-piperidinyl)-propyl-l,4… 
2005
2005
Conotoxin, a selective N-type channel blocker did not alter the B subunit-induced influx. However, either of the dihydropyridine… 
2001
2001
Abstract.Rationale: Various studies have shown that stressful manipulations in rats and mice lower the convulsant potency of GABA… 
1993
1993
Conotoxin, a selective N-type channel blocker did not alter the B subunit-induced influx. However, either of the dihydropyridine… 
1993
1993
Conotoxin, a selective N-type channel blocker did not alter the B subunit-induced influx. However, either of the dihydropyridine…